NCT01502904: Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents |
|
|
| Completed | 4 | 120 | RoW | Sirolimus-eluting stent, Biolimus-eluting stents, pravastatin 20mg/day after DES implantation, pitavastatin 2mg/day after DES implantation, Non-ARB /day after DES implantation, Eposartan 600mg/day after DES implantation | Yonsei University | Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension | 05/15 | 06/15 | | |
